High-flow nasal therapy costs more than low-flow oxygen in COAST

In Kenyan and Ugandan children with severe pneumonia and low blood oxygen, higher-tech oxygen delivery increased costs without better outcomes. In the COAST trial, high-flow nasal therapy cost more than low-flow oxygen for children with severe hypoxaemia. For children with less severe hypoxaemia, both high-flow nasal therapy and low-flow oxygen cost more than permissive hypoxaemia. […]